BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 28336204)

  • 1. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
    Tesic M; Seferovic J; Trifunovic D; Djordjevic-Dikic A; Giga V; Jovanovic I; Petrovic O; Marinkovic J; Stankovic S; Stepanovic J; Ristic A; Petrovic M; Mujovic N; Vujisic-Tesic B; Beleslin B; Vukcevic V; Stankovic G; Seferovic P
    J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy].
    Faludi R; Tóth L; Pótó L; Cziráki A; Simor T; Papp L
    Orv Hetil; 2005 Jan; 146(1):23-6. PubMed ID: 15715369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
    Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
    Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
    Thaman R; Esteban MT; Barnes S; Gimeno JR; Mist B; Murphy R; Collinson PO; McKenna WJ; Elliott PM
    Am J Cardiol; 2006 Aug; 98(4):515-9. PubMed ID: 16893708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.
    Kim SW; Park SW; Lim SH; Kwon SU; Choi YJ; Park MK; Lee SC; Lee SH; Park JE; Jeon ES
    Clin Cardiol; 2006 Apr; 29(4):155-60. PubMed ID: 16649724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
    Panou FK; Kotseroglou VK; Lakoumentas JA; Chrysanthopoulou SA; Armeniakos JA; Stratigou T; Veve H; Zacharoulis AA
    Hellenic J Cardiol; 2006; 47(6):344-51. PubMed ID: 17243506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
    Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
    Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of left ventricular diastolic function reserve index for predicting exercise capacity in patients with hypertrophic cardiomyopathy.
    Choi EY; Ha JW; Rim SJ; Kim SA; Yoon SJ; Shim CY; Kim JM; Jang Y; Chung N; Cho SY
    J Am Soc Echocardiogr; 2008 May; 21(5):487-92. PubMed ID: 17904804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis.
    Tesic M; Djordjevic-Dikic A; Beleslin B; Trifunovic D; Giga V; Marinkovic J; Petrovic O; Petrovic M; Stepanovic J; Dobric M; Vukcevic V; Stankovic G; Seferovic P; Ostojic M; Vujisic-Tesic B
    J Am Soc Echocardiogr; 2013 Jul; 26(7):775-82. PubMed ID: 23643850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients.
    Ceyhan C; Unal S; Yenisey C; Tekten T; Ceyhan FB
    Int J Cardiovasc Imaging; 2008 Mar; 24(3):253-9. PubMed ID: 17687631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.
    Yusoff R; Clayton N; Keevil B; Morris J; Ray S
    Am J Cardiol; 2006 May; 97(10):1498-501. PubMed ID: 16679092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of elevated NT-proBNP levels in patients with hypertrophic cardiomyopathy: an echocardiographic study.
    Kahveci G; Bayrak F; Mutlu B; Basaran Y
    Heart Lung Circ; 2009 Aug; 18(4):266-70. PubMed ID: 19157978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies.
    Mady C; Fernandes F; Arteaga E; Ramires FJ; Buck Pde C; Salemi VM; Ianni BM; Nastari L; Dias RR
    Arq Bras Cardiol; 2008 Jul; 91(1):46-54. PubMed ID: 18660945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
    Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction.
    Kim H; Jun DW; Cho YK; Nam CW; Han SW; Hur SH; Kim YN; Kim KB
    Echocardiography; 2008 Oct; 25(9):961-7. PubMed ID: 18771554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome.
    Ikonomidis I; Nikolaou M; Dimopoulou I; Paraskevaidis I; Lekakis J; Mavrou I; Tzanela M; Kopterides P; Tsangaris I; Armaganidis A; Kremastinos DT
    Shock; 2010 Feb; 33(2):141-8. PubMed ID: 19487972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings.
    Mak GS; DeMaria A; Clopton P; Maisel AS
    Am Heart J; 2004 Nov; 148(5):895-902. PubMed ID: 15523324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.